Eidos Therapeutics, Inc. - SEC Investigation Update

To access the full report, click on the PDF (only visible when logged-in).

Eidos Therapeutics, Inc. – EIDX:  Added to Watch List. The first FOIA response indicating an SEC investigation was dated 06-Mar-2019, and later confirmed in an appeal response dated 30-Apr-2019. This was our first time researching this company.  With new data reflected in this report, Eidos Therapeutics, Inc. is added to our Watch List of companies with confirmed, undisclosed SEC investigations.

To learn more on our process and what our findings mean, click here.

Notes: The SEC did not disclose the details on investigations referenced above. The SEC reminds us that its assertion of the law enforcement exemption should not be construed as an indication by the Commission or its staff that any violations of law have occurred with respect to any person, entity, or security.  New SEC investigative activity could theoretically begin or end after the date covered by this latest information which would not be reflected here.

This article is premium content. To continue reading, please Sign In or Join at the top of this page.